The long-term goal of a fully automated insulin delivery (AID) system that operates without user input to maintain glucose levels within target range remains a future aspiration and may never be fully ...
Palladyne AI’s flagship platform, Palladyne IQ, is redefining what robots can automate. By combining edge-based closed-loop AI with no-code programming, the system enables robots to adapt to real-time ...
People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With open-loop therapies*, insulin administration is manually controlled, while hybrid ...
Closed Loop Medicine Debuts WeDosify in US to Personalize GLP-1 Dosing and Improve Patient Adherence
The platform enables clinicians to tailor GLP-1 titration at scale, aiming to reduce discontinuation rates and improve ...
Until now, the effect of insulin delivery in hybrid closed-loop systems on the risk of acute diabetes complications in people with type 1 diabetes has been unclear. Researchers have therefore now ...
Sustainability: News about the rapidly growing climate tech sector and other areas of innovation to protect our planet. SEE MORE by Lisa Stiffler on Dec 9, 2024 at 9:00 am December 9, 2024 at 1:02 pm ...
Riders don’t care what kind of system you use. They care that it works and provides what they expect. They expect real-time updates, simple account management, and zero surprises. And public transit ...
UK medtech firm Closed Loop Medicine has launched its first product in the US, a digital tool for personalising the dose of ...
Closed Loop Medicine Ltd (CLM), a leader in personalized pharmaceutical dosing, today announced the U.S. launch of WeDosify, which enables clinicians to personalize GLP-1 titration at scale.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results